Siren Biotechnology Revenue and Competitors
Estimated Revenue & Valuation
- Siren Biotechnology's estimated annual revenue is currently $1.7M per year.
- Siren Biotechnology's estimated revenue per employee is $155,000
Employee Data
- Siren Biotechnology has 11 Employees.
- Siren Biotechnology grew their employee count by 0% last year.
Siren Biotechnology's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO, Founder, President | Reveal Email/Phone |
2 | Chief Staff | Reveal Email/Phone |
3 | VP Vector Development for Translational Gene Therapies | Reveal Email/Phone |
4 | VP Vector Development | Reveal Email/Phone |
5 | VP Vector Development for Translational Gene Therapies | Reveal Email/Phone |
6 | Director Corporate Strategy | Reveal Email/Phone |
Siren Biotechnology Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Siren Biotechnology?
The fight against cancer needs new, big, bold ideas. At Siren, we’ve got one: Universal AAV Immuno-Gene Therapy.\nWe are combining two transformative therapeutic technologies – AAV gene therapy and cytokine immunotherapy - into a single, reimagined modality that overcomes key challenges and redefines how we destroy tumor cells and elicit anti-tumor immunity.
keywords:N/AN/A
Total Funding
11
Number of Employees
$1.7M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.1M | 11 | -27% | N/A |
#2 | $1.7M | 11 | -27% | N/A |
#3 | $0.4M | 11 | 22% | N/A |
#4 | $0.4M | 11 | -8% | $20M |
#5 | $1M | 11 | N/A | N/A |